Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare-Bloomington
mi
from
Bloomington, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare-Bloomington
mi
from
Bloomington, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Canton
mi
from
Canton, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Canton
mi
from
Canton, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Carthage
mi
from
Carthage, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Carthage
mi
from
Carthage, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Louis A. Weiss Memorial Hospital
mi
from
Chicago, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Louis A. Weiss Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Resurrection Medical Center
mi
from
Chicago, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Resurrection Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Eureka
mi
from
Eureka, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Eureka
mi
from
Eureka, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Eureka Community Hospital
mi
from
Eureka, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Eureka Community Hospital
mi
from
Eureka, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Havana
mi
from
Havana, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Havana
mi
from
Havana, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Kewanee Clinic
mi
from
Kewanee, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Kewanee Clinic
mi
from
Kewanee, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Macomb
mi
from
Macomb, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Macomb
mi
from
Macomb, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Monmouth
mi
from
Monmouth, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Monmouth
mi
from
Monmouth, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
OSF Holy Family Medical Center
mi
from
Monmouth, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
OSF Holy Family Medical Center
mi
from
Monmouth, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Community Cancer Center
mi
from
Normal, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Community Cancer Center
mi
from
Normal, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
BroMenn Regional Medical Center
mi
from
Normal, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
BroMenn Regional Medical Center
mi
from
Normal, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Community Cancer Center
mi
from
Normal, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Community Cancer Center
mi
from
Normal, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Pekin
mi
from
Pekin, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Pekin
mi
from
Pekin, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
OSF St. Francis Medical Center
mi
from
Peoria, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
OSF St. Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Proctor Hospital
mi
from
Peoria, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Proctor Hospital
mi
from
Peoria, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Peru
mi
from
Peru, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Peru
mi
from
Peru, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois Valley Community Hospital
mi
from
Peru, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois Valley Community Hospital
mi
from
Peru, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Princeton
mi
from
Princeton, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Princeton
mi
from
Princeton, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Illinois CancerCare - Spring Valley
mi
from
Spring Valley, IL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Illinois CancerCare - Spring Valley
mi
from
Spring Valley, IL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
McFarland Clinic, PC
mi
from
Ames, IA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas - Fort Scott
mi
from
Fort Scott, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas - Fort Scott
mi
from
Fort Scott, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas-Independence
mi
from
Independence, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas-Independence
mi
from
Independence, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - Liberal
mi
from
Liberal, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - Liberal
mi
from
Liberal, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Associates in Womens Health, PA - North Review
mi
from
Wichita, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Associates in Womens Health, PA - North Review
mi
from
Wichita, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Via Christi Cancer Center at Via Christi Regional Medical Center
mi
from
Wichita, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Via Christi Cancer Center at Via Christi Regional Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Center of Kansas, PA - Winfield
mi
from
Winfield, KA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Center of Kansas, PA - Winfield
mi
from
Winfield, KA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
mi
from
Baltimore, MD
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Peninsula Regional Medical Center
mi
from
Salisbury, MD
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Peninsula Regional Medical Center
mi
from
Salisbury, MD
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Hickman Cancer Center at Bixby Medical Center
mi
from
Adrian, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Hickman Cancer Center at Bixby Medical Center
mi
from
Adrian, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Saint Joseph Mercy Cancer Center
mi
from
Ann Arbor, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Saint Joseph Mercy Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Oakwood Cancer Center at Oakwood Hospital and Medical Center
mi
from
Dearborn, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Oakwood Cancer Center at Oakwood Hospital and Medical Center
mi
from
Dearborn, MI
Click here to add this to my saved trials